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Abstract
Introduction Acute transverse myelitis (ATM) is a rare
disorder (1–8 new cases per million of population per
year), with 20% of all cases occurring in patients younger
than 18 years of age. Diagnosis requires clinical symptoms
and evidence of inflammation within the spinal cord
(cerebrospinal fluid and/or magnetic resonance imaging).
ATM due to neuroborreliosis typically presents with
impressive clinical manifestations.
Case presentation Here we present a case of Lyme
neuroborreliosis-associated ATM with severe MRI and
CSF findings, but surprisingly few clinical manifestations
and late conversion of the immunoglobulin G CSF/blood
index of Borrelia burgdorferi sensu lato.
Conclusion Clinical symptoms and signs of neuroborre-
lial ATM may be minimal, even in cases with severe
involvement of the spine, as shown by imaging studies.
The CSF/blood index can be negative in the early stages
and does not exclude Lyme neuroborreliosis; if there is
strong clinical suspicion of Lyme neuroborreliosis, appro-
priate treatment should be started and the CSF/blood index
repeated to confirm the diagnosis.
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Introduction
Acute transverse myelitis (ATM) is an inflammatory
myelopathy with an incidence of 1–8 cases per million of
population per year. Of all affected patients, 20% are
younger than 18 years of age [1]. Diagnosis is based on
clinical symptoms, cerebral spinal fluid (CSF) findings and
spinal neuroimaging results. In addition to the inflamma-
tory myelopathies, demyelination, infection (e.g. poly-
myelitic enteroviral infection) and other inflammatory
disorders (i.e. systemic lupus erythematodes, neurosar-
coidosis) must be considered in the differential diagnosis
[2, 3]. In adults, multiple sclerosis and neuromyelitis optica
together with infectious/parainfectious aetiologies are the
most frequent causes of ATM [4], while in children the
aetiology is mainly postinfectious [5]. Clinical features
consist of sensory disturbances in most of the patients,
followed by weakness and—especially in childhood—uri-
nary tract dysfunction. Children suffer from more severe
clinical impairment then adults. In the series of Pidcock
et al., 89% of the paediatric patients were bed- or wheel-
chair bound or required assisted ventilation, whereas the
majority of adults showed only mild impairment [1, 6].
Outcome is generally favourable. Chronic bladder dys-
function has been shown to be the main sequelae [1].
ATM due to Lyme neuroborreliosis has rarely been
reported. However, those cases that have been documented,
the majority of patients presented with impressive clinical
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symptoms [7–9]. Here, we report a case of ATM due to
Lyme neuroborreliosis, which—despite severe neuroim-
aging (magnetic resonance imagining, MRI) and CSF
findings—was characterized by surprisingly few clinical
signs.
Case report
A 12.5-year-old boy presented to our emergency depart-
ment in November with a [4-week history of increasing
frontal headache that got worse in the evening. He noted
intermittent subfebrile temperatures. Additional complaints
were fatigue, diffuse non-radicular back/neck pain and
nausea. There was no vomiting. In this period, a weight
loss of 2–3 kg was documented. Three weeks before
admission he had been immunized (dTap = diphtheria,
tetanus, acellular pertussis) according to the recommended
Swiss vaccination schedule. His personal history is unre-
markable. There was no tick bite reported, and no an ery-
thema migrans.
On admission, the general physical condition of the
patient was slightly lower than would normally be expec-
ted, he was afrebrile, and the results of a general clinical
examination were normal. His neurological examination
was remarkable only for nuchal rigidity. In particular, there
was no bladder dysfunction, and there was no sensory
disturbance or weakness.
Laboratory investigations on admission included a nor-
mal complete blood cell count, inflammatory markers
(C-reactive protein), liver enzymes and kidney function
parameters.
Because of the clinical constellation (neck stiffness in an
afebrile patient), MRI of the brain was performed to
exclude a haemorrhagic or space-occupying lesion. The
brain scan was normal, but there were signal alterations
(T2w hyperintensities) within the medulla down to cervical
spine. A consecutive MRI of the spinal cord was added to
the tests, which revealed a longitudinal signal alteration
(T2w hyperintensities) from the pons to the conus, accen-
tuated centromedullarily with a patchy enhancement
(Fig. 1). The myelon was swollen, especially in the cer-
vical region. There was no tumor or cerebral or meningeal
enhancement on the MRI scan.
There was marked CSF pleocytosis (787cells/ll; 734
mononuclear cells), elevated protein (6.24 g/l) and
decreased glucose (1.79 mmol/l), with a glucose CSF/
plasma ratio of 0.28. Microbiological investigation
revealed increased serum immunoglobulin G (IgG) and
IgM for Epstein–Barr virus (EBV) (EBV viral capsid
antigen-IgM and -IgG, anti-early-antigen IgG p54) and
Borrelia burgdorferi sensu lato. Serological testing for
Fig. 1 Left T2-weighted
sagittal scan of the
cervicothoracic spine. There is
an extensive centromedullary
hyperintensity (arrow) and
swelling as an expression of the
spinal cord edema. Right
T2-weighted axial scan at the
level of the cervical spine.
The edema involving the gray
and white matter is discernible.
The hyperintensity of the gray
matter (arrow) is particularly
prominent
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B. burgdorferi was performed using a recomWell enzyme-
linked immunosorbent assay (ELISA; IgM and IgG;
Mikrogen, Neuried, Germany) and confirmed by recomBlot
(Mikrogen; IgM and IgG). The Western blot revealed that
the patient had borrelia-specific positive IgM and IgG
bands that were distributed as follows: anti-OspC IgM
(B. burgdorferi sensu lato); anti-p41 flagellin IgM; anti-p41
intern IgM (B. afzelii); anti-VisE IgG (B. afzelii); anti-p41
flagellin IgG; anti-p41-intern IgG (B. garinii); anti-p41-
intern IgG (B. afzelii). The EBV DNA PCR of the CSF and
the CSF/blood index for B. burgdorferi sensu lato IgM and
IgG were negative. The CSF/blood index was performed
using the IDEIA test (Oxoid, Cambridge, UK) for Lyme
neuroborreliosis. The results of the CSF PCR for herpes
simplex virus (HSV) and enteroviruses were negative.
With the suspicion of Lyme neuroborreliosis, ceftriax-
one therapy for 14 days was started. Antiviral therapy with
aciclovir was added at the beginning of the therapeutic
regimen and stopped when the negative HSV PCR result
became available. Steroids had not been given. The patient
recovered almost completely within the first 24 h of ther-
apy, with only residual mild neck stiffness that persisted for
1 week. Eight days after the initiation of therapy, a follow-
up MRI of the spinal cord showed improvement with
reduced swelling and less signal alteration (Fig. 2).
Three weeks after admission, an outpatient control
showed a completely normal clinical examination. In the
follow-up lumbar puncture performed at this time, 27 cells/ll
were detected (all mononuclear). Protein and glucose
(including CSF/plasma ratio) were normal. Examination of
the oligoclonal IgG bands in the CSF/serum revealed an
intrathecal IgG production. The IgG CSF/blood index for
B. burgdorferi sensu lato was 41.73 (\0.3), and the EBV
DNA PCR of the CSF remained negative.
Discussion
Lyme neuroborreliosis as a cause of ATM is known, but
reports are limited to single cases, both in children and
adults. The usual manifestations are severe and often
include dramatic signs of motor weakness and bladder
dysfunction [7]. In discussing our case, we wish to
emphasize two aspects which—to the best of our knowl-
edge—have not been reported to date: the striking dis-
crepancy between the severe imaging manifestations and
the minimal clinical signs and symptoms, and the promi-
nent MRI findings involving most of the medulla spinalis
in a patient with transverse myelitis of borrelial origin. In
pediatric Lyme neuroborreliosis, CNS symptoms are
rare—in contrast to symptoms of the peripheral nervous
system. Children with CNS symptoms may present with
acute myelitis. In all such cases reported so far, the children
suffered from acute symptoms due to their myelitis, such as
Fig. 2 Left T2-weighted
sagittal scan of the
cervicothoracic spine. The
centromedullary edema is
regressive but still visible. Right
T2-weighted axial scan at the
level of the cervical spine.
Central hyperintensity with
accentuation in the central grey
matter was present, but was less
marked than in the initial scan
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pareses, urinary tract dysfunction and sensory disturbances.
All of these symptoms and signs were lacking in our
patient, possibly because of the early diagnosis and treat-
ment [10]. The description of an extension to spine
involvement in a transverse myelitis of borrelial origin in
children is limited to single case reports. In these case
reports, the involvement of the spine is limited and mostly
cervically [7, 11]. At the moment of first lumbar puncture,
our patient had a symptom duration of \6 weeks, which
explains the first negative CSF/blood index, as delayed
intrathecal antibody synthesis in Lyme neuroborreliosis
(positive CSF/blood index) is well known in patients with a
symptom duration of \6 weeks. Therefore, the positive
CSF/blood index in the follow-up lumbar puncture con-
firms the assumed diagnosis of Lyme neuroborreliosis, and
early detection and treatment may have prevented further
progression of the disease. [12–14] In the literature, EBV—
in addition to many other occasionally incriminated viru-
ses—is a rare but recognized agent causing ATM [5, 15].
Serologically, our patient had a co-infection with EBV at
the time of his CNS manifestation, even though there was
no classic mononucleosis (tonsillitis, lymphadenopathy,
hepatosplenomegaly) and the EBV DNA PCR of the CFS
remained negative over time. We conclude that the ATM
was related to Lyme neuroborreliosis and not to the EBV
infection. However, this patient most likely has had a
recent infection with EBV, which may or may not have
paved the way for progression of early, local borreliosis to
Lyme neuroborreliosis.
Single cases of ATM after vaccination have been
reported, but in these, in contrast to our case, there were no
other aetiological findings. Pidcock et al. reported that 28%
of the reported children with ATM received immunization
or ‘‘allergy shots’’ within 30 days prior to onset, but they
could not demonstrate a potential causal link between
vaccination and ATM. In our case, the onset of symptoms
1 week prior to vaccination renders a vaccine-related
adverse effect unlikely, but the possibility of vaccination
supporting the development of Lyme neuroborreliosis
because of an already present infection cannot be entirely
ruled out or resolved.
In conclusion, we report the case of a patient with ATM
caused by Lyme neuroborreliosis with surprisingly few
clinical signs—in contrast to the severe MRI and CSF
findings. If there is strong clinical suspicion of Lyme
neuroborreliosis—irrespective of a history of a recent tick
bite or erythema migrans—appropriate treatment should be
started, and the CSF/blood index should be repeated to
confirm the diagnosis if the initial results are negative.
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